Xylem (NYSE:XYL) Stock Gets Price Target Reduction from Citigroup

Xylem (NYSE:XYL) had its target price decreased by Citigroup from $148.00 to $130.00 in a research note issued to investors on Wednesday,Benzinga reports. Citigroup currently has a buy rating on the industrial products company’s stock.

Several other research analysts have also commented on the stock. Wolfe Research started coverage on shares of Xylem in a research note on Tuesday, September 15th. They issued a “peer perform” rating for the company. Mizuho set a $99.00 price target on shares of Xylem in a research report on Wednesday. UBS Group dropped their price target on shares of Xylem from $138.00 to $112.00 and set a “neutral” rating for the company in a research note on Monday, October 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Xylem in a research report on Wednesday, August 5th. Finally, BNP Paribas Exane cut their price objective on Xylem from $145.00 to $135.00 and set an “outperform” rating on the stock in a research report on Wednesday. Nine equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $121.31.

Xylem Price Performance

Shares of NYSE XYL opened at $92.41 on Wednesday. The firm has a 50-day simple moving average of $105.05 and a 200-day simple moving average of $117.57. The stock has a market capitalization of $21.19 billion, a price-to-earnings ratio of 20.44, a price-to-earnings-growth ratio of 1.51 and a beta of 1.00. The company has a quick ratio of 1.24, a current ratio of 1.39 and a debt-to-equity ratio of 0.23. Xylem has a 52 week low of $87.40 and a 52 week high of $152.43.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The company had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.28 billion. During the same period last year, the firm posted $1.37 EPS. The business’s quarterly revenue was down 3.0% on a year-over-year basis. On average, equities analysts predict that Xylem will post 5.45 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.9%. Xylem’s dividend payout ratio (DPR) is presently 40.95%.

Insider Buying and Selling at Xylem

In related news, Director D Koch purchased 11,000 shares of the business’s stock in a transaction dated Thursday, October 29th. The stock was bought at an average cost of $89.60 per share, with a total value of $985,600.00. Following the completion of the acquisition, the director directly owned 12,247 shares in the company, valued at $1,097,331.20. The trade was a 882.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.32% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Xylem

Several hedge funds have recently made changes to their positions in XYL. Jmac Enterprises LLC acquired a new position in shares of Xylem in the 3rd quarter valued at $537,000. Covestor Ltd boosted its position in shares of Xylem by 38.5% in the third quarter. Covestor Ltd now owns 583 shares of the industrial products company’s stock worth $59,000 after buying an additional 162 shares during the period. Markel Group Inc. purchased a new stake in shares of Xylem in the third quarter worth about $1,244,000. Putney Financial Group LLC purchased a new stake in shares of Xylem in the third quarter worth about $73,000. Finally, Mountain Pacific Investment Advisers LLC grew its stake in shares of Xylem by 5.5% in the third quarter. Mountain Pacific Investment Advisers LLC now owns 141,766 shares of the industrial products company’s stock valued at $14,357,000 after buying an additional 7,403 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem News Summary

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
• Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
• Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
• Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
• Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.